EquasensFRA:PHF 94 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates FRA:PHF with a GF Score™ of 94/100 and a GF Value™ of €85.23. The stock has 2 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Equasens ranks better than 64.36% on this metric.
The historical rank and industry rank for Equasens's Days Payable or its related term are showing as below:
FRA:PHF'
s Days Payable Range Over the Past 10 Years
Min: 58.91 Med: 84.86 Max: 95.96
Current: 82.87
During the past 13 years, Equasens's highest Days Payable was 95.96. The lowest was 58.91. And the median was 84.86.
FRA:PHF's Days Payable is ranked better than 64.36% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs FRA:PHF: 82.87
Equasens's Days Payable
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
Equasens Days Payable Related Terms
Equasens Days Payable Historical Data
* Premium members only.
The historical data trend for Equasens's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PHF vs VEEV, BTSG, TEM: Days Payable Comparison
For the Health Information Services subindustry, Equasens's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Equasens Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Equasens's Days Payable distribution charts can be found below:
* The bar in red indicates where Equasens's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Equasens's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equasens (FRA:PHF) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Equasens and its competitors. Over the past decade, Equasens' Days Payable has ranged from 58.91 to 95.96. According to the industry distribution chart, Equasens ranks #216 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 35.6%.
Is Equasens' Days Payable too high?
Equasens' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 58.91 to a high of 95.96. Based on the distribution chart, Equasens ranks #216 out of 606 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Equasens has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Equasens' Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Equasens ranks #216 out of 606 companies for Days Payable. This puts Equasens in the upper half of its industry. The industry median Days Payable is 58.21. Historically, Equasens' own Days Payable has ranged from 58.91 to 95.96 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Equasens and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Equasens's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Equasens stock overvalued right now?
Equasens (FRA:PHF) has a current Days Payable of 0.00. The stock's GF Value™ is €85.23, compared to a current price of €52.77 — trading 38.1% below its estimated fair value. The current Days Payable is 0.00. Equasens' overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Equasens (FRA:PHF), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Equasens (FRA:PHF) Overvalued in 2026?
Based on GuruFocus' analysis, Equasens stock appears to be undervalued.
The current stock price of €52.77 is trading 38.1% below its estimated GF Value™ of €85.23.
Key valuation signals for FRA:PHF:
Days Payable: 0.00
GF Value™: €85.23 vs. price of €52.77 (38.1% below fair value)
No single metric tells the full story. See the FRA:PHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
94GF Score
Get the complete analysis for FRA:PHF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PHF has been successfully added to your 
